PER 4.00% 7.2¢ percheron therapeutics limited

Ann: ANP and MCRI new R&D collaboration for ATL1102, page-48

  1. 236 Posts.
    lightbulb Created with Sketch. 59
    On 25th March MD stated that they will need the funds for the P2B trial within the next 3-6 months, we have just past the
    3 month time frame. The count down is on
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.